The Network between Heart and Liver from the View of Persian Medicine Versus Conventional Medicine

Heart-Liver Network

Authors

  • Azadeh Zarei Department of Traditional Persian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Mehrdad Karimi Department of Traditional Persian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Hossein Rezaeizadeh Department of Traditional Persian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.31661/gmj.v12i.2557

Keywords:

Heart Diseases, Liver Diseases, Network Medicine

Abstract

Background: Liver and heart are two important organs in the human body, whose function strongly affects other organs. On the other hand, these two main organs affect each other due to common metabolic pathways. Therefore, a disorder in any of them can lead to disease in other organs. Today, using the network medicine perspective, these complex connections can be easily mapped and discovered. From the Persian medicine viewpoint, links are formed based on the material causes of diseases, while from the conventional medicine viewpoint, they are mostly formed due to metabolites, genes, and pathways. Materials and Methods: In this article, we first investigated the recent articles of conventional medicine that examine the relationship between heart and liver in the important databases. Then, we checked out the sources of Persian medicine and finally, using the RStudio software used in network medicine for text mining, we drew the communication network centered on heart and liver and their mutual causes from the perspective of Persian Medicine. Results: Examining the network connection between the heart and the liver showed that the definitions based on Persian medicine, which are based on the material causes of diseases, are very compatible with the genes, metabolites and pathways between these two organs. Conclusion: Understanding these concepts can be helpful in detecting the co-occurrence of diseases of these two organs, as well as predicting the possible occurrence of related diseases between the heart and liver, and ultimately in better treatment.

References

Zeb I, Li D, Budoff MJ, Katz R, Lloyd-Jones D, Agatston A, et al. Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis. JACC . 2016;67(16):1965-6.

https://doi.org/10.1016/j.jacc.2016.01.070

PMid:27102512

VanWagner LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, Carr JJ, Lima JA, et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology. 2015;62(3):773-83.

https://doi.org/10.1002/hep.27869

PMid:25914296 PMCid:PMC4549239

Vita T, Murphy DJ, Osborne MT, Bajaj NS, Keraliya A, Jacob S, et al. Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET/CT. Radiology. 2019;291(2):330-7.

https://doi.org/10.1148/radiol.2019181793

PMid:30835188 PMCid:PMC6492883

Ito M, Adachi-Akahane S. Inter-organ communication in the regulation of lipid metabolism: focusing on the network between Liver, intestine, and Heart. Journal of pharmacological sciences. 2013:13R09CP.

https://doi.org/10.1254/jphs.13R09CP

PMid:24304723

Ambale Venkatesh B, Lima JA. Probing Liver Heart Axis. Radiological Society of North America. 2019;291(2):338-9.

https://doi.org/10.1148/radiol.2019190264

PMid:30835190

Baskin KK, Bookout AL, Olson EN. The Heart-liver metabolic axis: defective communication exacerbates disease. EMBO molecular medicine. 2014;6(4):436-8.

https://doi.org/10.1002/emmm.201303800

PMid:24623378 PMCid:PMC3992070

Avicenna (Ibn Sina). The canon of medicine. Beirut, Lebanon: Institute Dare Ehya al-Toras; 2005.

Azam Khan M. Exir Azam [Persian] Tehran,Iran: Institute of Meical History, Islamic Medicine and Complementary Medicine; 2008.

Zargaran A, Mehdizadeh A, Zarshenas MM, Mohagheghzadeh A. Avicenna (980-1037 AD). Journal of neurology. 2012;259(2):389-90.

https://doi.org/10.1007/s00415-011-6219-2

PMid:21887514

Aghili Shirazi MH. Moalejat-e Aghili (Persian). Tehran: Institute of Meical History, Islamic Medicine and Complementary Medicine; 2008.

Chou E. Mastering Python Networking. Birmingham: Packt Publishing Ltd; 2017.

Kronthaler F, Zöllner S. Data Analysis with RStudio: Springer; 2021.

https://doi.org/10.1007/978-3-662-62518-7

Shirbeigi L, Zarei A, Naghizadeh A, Vaghasloo MA. The concept of temperaments in traditional Persian medicine. Traditional and Integrative Medicine. 2017:143-56.

Zarei A, Noroozi S, Khadem E. A Review on the Structure and Function of Liver from Avicenna Point of View and Its Comparison with Conventional Medicine. Traditional and Integrative Medicine. 2019;18:28-36.

https://doi.org/10.18502/tim.v4i1.1666

Zarei A, Rezaeizadeh H, Karimi M. Persian Medicine Perspective on the Network Between Liver and Other Organs. Hepatitis Monthly. 2021;21(11):e123088.

https://doi.org/10.5812/hepatmon-123088

Rezadoost H, Karimi M, Jafari M. Proteomics of hot-wet and cold-dry temperaments proposed in Iranian traditional medicine: a Network-based Study. Scientific reports. 2016;6(1):1-8.

https://doi.org/10.1038/srep30133

PMid:27452083 PMCid:PMC4959000

Jorjani E. zakhire kharazmshahi[in persian]. Tehran: Iranian Medical Academy; 2001.

Aghili M. Kholase al hekmah. Quom, Iran: Esmailian. 2006:35-42.

Kermani N-I-E. Sharh-al-Asbab V-al-Alamaat. Tehran: Tehran University of Medical Sciences; 2004.

Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic Heart failure: prevalence, characteristics and prognostic significance. European journal of clinical investigation. 2012;42(2):153-63.

https://doi.org/10.1111/j.1365-2362.2011.02573.x

PMid:21806605

Kazantzis M, Stahl A. Fatty acid transport proteins, implications in physiology and disease. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2012;1821(5):852-7.

https://doi.org/10.1016/j.bbalip.2011.09.010

PMid:21979150 PMCid:PMC3274620

Vela D. Balance of cardiac and systemic hepcidin and its role in Heart physiology and pathology. Laboratory investigation. 2018;98(3):315-26.

https://doi.org/10.1038/labinvest.2017.111

PMid:29058707

Hernandez-Anzaldo S, Berry E, Brglez V, Leung D, Yun TJ, Lee JS, et al. Identification of a novel Heart-liver axis: matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate lipid metabolism and inflammation in Liver. Journal of the American Heart Association. 2015;4(11):e002553.

https://doi.org/10.1161/JAHA.115.002553

PMid:26567374 PMCid:PMC4845223

Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Kawamoto A, et al. Analysis of liver metabolism in a rat model of Heart failure. International journal of cardiology. 2012;161(3):130-6.

https://doi.org/10.1016/j.ijcard.2011.07.056

PMid:21839528

Tang T-T, Li Y-Y, Li J-J, Wang K, Han Y, Dong W-Y, et al. Liver-Heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction. Theranostics. 2018;8(16):4552.

https://doi.org/10.7150/thno.24723

PMid:30214638 PMCid:PMC6134935

Mantovani A. Nonalcoholic fatty liver disease (NAFLD) and risk of cardiac arrhythmias: a new aspect of Liver-Heart axis. Journal of clinical and translational hepatology. 2017;5(2):134.

https://doi.org/10.14218/JCTH.2017.00005

PMid:28660151 PMCid:PMC5472934

Ambale Venkatesh B, Lima JA. Probing Liver Heart Axis. Radiological Society of North America. 2019;291(2): 338-9.

https://doi.org/10.1148/radiol.2019190264

PMid:30835190

Mukhopadhyay R. Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation. Journal of applied genetics. 2013;54(2):185-92.

https://doi.org/10.1007/s13353-013-0134-4

PMid:23361320

Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis. 2010;211(1):182-6.

https://doi.org/10.1016/j.atherosclerosis.2010.01.049

PMid:20181335

Ostovaneh MR, Ambale-Venkatesh B, Fuji T, Bakhshi H, Shah R, Murthy VL, et al. Association of liver fibrosis with cardiovascular diseases in the general population: the multi-ethnic study of atherosclerosis (MESA). Circulation: Cardiovascular Imaging. 2018;11(3):e007241.

https://doi.org/10.1161/CIRCIMAGING.117.007241

PMid:29523555 PMCid:PMC5846116

de Bold AJ. Thirty years of research on atrial natriuretic factor: historical background and emerging concepts. Canadian journal of physiology and pharmacology. 2011;89(8):527-31.

https://doi.org/10.1139/y11-019

PMid:21671768

Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in Heart failure and its relation to the severity of tricuspid regurgitation. American Journal of Cardiology. 2002;90(12):1405-9.

https://doi.org/10.1016/S0002-9149(02)02886-2

PMid:12480058

Vasconcelos LABA, Almeida EAd, Bachur LF. Clinical evaluation and hepatic laboratory assessment in individuals with congestive Heart failure. Arquivos brasileiros de cardiologia. 2007;88:590-5.

https://doi.org/10.1590/S0066-782X2007000500015

PMid:17589636

Correale M, Tarantino N, Petrucci R, Tricarico L, Laonigro I, Di Biase M, et al. Liver disease and Heart failure: Back and forth. European Journal of Internal Medicine. 2018;48:25-34.

https://doi.org/10.1016/j.ejim.2017.10.016

PMid:29100896

Alvarez AM, Mukherjee D. Liver abnormalities in cardiac diseases and Heart failure. International Journal of Angiology. 2011;20(03):135-42.

https://doi.org/10.1055/s-0031-1284434

PMid:22942628 PMCid:PMC3331650

Yamada T, Kotake Y, Nagata H, Takeda J. Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits. Journal of anesthesia. 2013;27(6):901-8.

https://doi.org/10.1007/s00540-013-1643-3

PMid:23736823

Noghani MT, Namdar H. Migraine associated with gastrointestinal disorders: a pathophysiological explanation. Medical hypotheses. 2019;125:90-3.

https://doi.org/10.1016/j.mehy.2019.02.041

PMid:30902160

Horvatits T, Drolz A, Rutter K, Roedl K, Kluge S, Fuhrmann V. Hepatocardiac disorders. World J Hepatol. 2014;6(1):41-54.

https://doi.org/10.4254/wjh.v6.i1.41

PMid:24653793 PMCid:PMC3953805

Nakamura M, Sadoshima J. Heart over mind: metabolic control of white adipose tissue and liver. EMBO Molecular Medicine. 2014;6(12):1521-4.

https://doi.org/10.15252/emmm.201404749

PMid:25471454 PMCid:PMC4287972

Ghaderi. Fosool-Ol-Aaraz. Tehran: Iran University of Medical Sciences; 2008.

Ibn-abbas A. Kamel-Al-sana-ah-Al-Tebbiah. Qom: Jalal-el-Din; 2008.

Downloads

Published

2023-04-18

How to Cite

Zarei, A., Karimi, M., & Rezaeizadeh, H. (2023). The Network between Heart and Liver from the View of Persian Medicine Versus Conventional Medicine: Heart-Liver Network. Galen Medical Journal, 12, e2557. https://doi.org/10.31661/gmj.v12i.2557

Issue

Section

Original Article